6.
Dehail P, Gaudreault N, Zhou H, Cressot V, Martineau A, Kirouac-Laplante J
. Joint contractures and acquired deforming hypertonia in older people: Which determinants?. Ann Phys Rehabil Med. 2018; 62(6):435-441.
DOI: 10.1016/j.rehab.2018.10.005.
View
7.
Hacker M, Ploucher S, Naik A, Turchan M, Meystedt J, Harper K
. A Simple Bedside Screening Tool for Spasticity Referral. Clin Interv Aging. 2020; 15:655-662.
PMC: 7234972.
DOI: 10.2147/CIA.S248602.
View
8.
Trudel G, Uhthoff H, Brown M
. Extent and direction of joint motion limitation after prolonged immobility: an experimental study in the rat. Arch Phys Med Rehabil. 1999; 80(12):1542-7.
DOI: 10.1016/s0003-9993(99)90328-3.
View
9.
Krasny-Pacini A, Hiebel J, Pauly F, Godon S, Chevignard M
. Goal attainment scaling in rehabilitation: a literature-based update. Ann Phys Rehabil Med. 2013; 56(3):212-30.
DOI: 10.1016/j.rehab.2013.02.002.
View
10.
Chol C, Blanchon M, Le Quang B, Celarier T, Gonthier R
. [Botulinum toxin in the elderly to the care of limbs spastic hypertonia and toes or fingers dystonias]. Geriatr Psychol Neuropsychiatr Vieil. 2012; 10(1):17-26.
DOI: 10.1684/pnv.2012.0314.
View
11.
Turner-Stokes L
. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009; 23(4):362-70.
DOI: 10.1177/0269215508101742.
View
12.
Levy J, Karam P, Forestier A, Loze J, Bensmail D
. Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France. Front Neurol. 2023; 14:1245228.
PMC: 10482253.
DOI: 10.3389/fneur.2023.1245228.
View
13.
Tosto G, Monsell S, Hawes S, Mayeux R
. Pattern of extrapyramidal signs in Alzheimer's disease. J Neurol. 2015; 262(11):2548-56.
PMC: 4776751.
DOI: 10.1007/s00415-015-7886-1.
View
14.
Lam K, Lau K, So K, Tam C, Wu Y, Cheung G
. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study. J Am Med Dir Assoc. 2012; 13(5):477-84.
DOI: 10.1016/j.jamda.2012.03.005.
View
15.
Kleiner-Fisman G, Khoo E, Moncrieffe N, Forbell T, Gryfe P, Fisman D
. A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment. PLoS One. 2014; 9(12):e114733.
PMC: 4275182.
DOI: 10.1371/journal.pone.0114733.
View
16.
Park H, Chung S
. New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord. 2014; 6(1):1-8.
PMC: 4027647.
DOI: 10.14802/jmd.13001.
View
17.
Dent E, Kowal P, Hoogendijk E
. Frailty measurement in research and clinical practice: A review. Eur J Intern Med. 2016; 31:3-10.
DOI: 10.1016/j.ejim.2016.03.007.
View
18.
McMahon H, Foran P, Dolly J, Verhage M, Wiegant V, Nicholls D
. Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem. 1992; 267(30):21338-43.
View
19.
Wagner L, Clevenger C
. Contractures in nursing home residents. J Am Med Dir Assoc. 2010; 11(2):94-9.
DOI: 10.1016/j.jamda.2009.04.010.
View
20.
Fischer U, Muller M, Strobl R, Bartoszek G, Meyer G, Grill E
. Prevalence of functioning and disability in older patients with joint contractures: a cross-sectional study. Eur J Phys Rehabil Med. 2014; 51(3):269-79.
View